Amarin Corp Plc (AMRN)

[Whalatane]

And there we disagree. Dr Bhatt and others have been promoting the excellent risk reduction numbers seen in the R-IT trial for years ....and its largely ignored.
Classic example is the response to the PCI data presented yesterday at ACC.

If the Cardiology community accepted those PCI numbers ...almost everyone who has a PCI would be prescribed Vascepa ( brand or generic ) going forward . Scripts #'s would really jump.
So if theres little change in script numbers this month ...tell me why ?

Its not because Vascepa is not being promoted .
Dr Bhatt and others are promoting it every chance they get.....to those most likely to prescribe ...at conferences like ACC.

Why are U afraid of independent confirming data anyway ?

CV data from MITIGATE ...if collected long enough ...will provide important independent data... re risk reduction using Vascepa
Kiwi